Publication | Closed Access

Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study

RheumatologySpondyloarthritisRheumatic DiseasesDouble-blind StudyClinical TrialsAdalimumab TherapyInflammatory Rheumatic DiseaseMedicineOrthopaedic SurgeryNon-radiographic Axial SpondyloarthritisAxial Spondyloarthritis